NAKEETSHA DRYER: Open Payments
NPI 1518217876 · FORT PAYNE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,785 in 90 payments from 13 companies in 2025. Trend: 2023 $1,816 · 2024 $2,003 · 2025 $1,785
Food & beverage: $1,785
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $594 |
| ABBVIE INC. | 11 | $239 |
| Neurocrine BioSciences, Inc. | 7 | $177 |
| Otsuka America Pharmaceutical, Inc. | 12 | $172 |
| Braeburn Inc. | 9 | $170 |
| Axsome Therapeutics, Inc. | 11 | $163 |
| Vanda Pharmaceuticals Inc. | 4 | $106 |
| E.R. Squibb & Sons, L.L.C. | 1 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Corium, LLC | 3 | $34 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, REXULTI, BRIXADI, Auvelity, FANAPT, COBENFY.
Industry payments across AL — which companies pay providers there.
